Unlocking hypoglycemia–associated brain microvascular dysfunction:critical insights from proteomic analysis  

作　　者：Siva S.V.P.Sakamuri Anil Sakamuri 

机构地区：[1]Department of Chemistry,Auburn University at Montgomery,Montgomery,AL,USA [2]Vascular Biology Center and Department of Medicine,Medical College of Georgia at Augusta University,Augusta,GA,USA

出　　处：《Neural Regeneration Research》2025年第6期1707-1708,共2页中国神经再生研究（英文版）

基　　金：generously supported by the faculty startup funds from Auburn University at Montgomery (to SSVPS)。

摘　　要：Hypoglycemia-a critical complication linked to worsened brain function in diabetic subjects:Hypoglycemia is characterized by a decline in circulatory glucose levels below sta nda rd physiological thresholds.Mild hypoglycemia,classified as level 1 hypoglycemia,is defined by blood glucose levels below 70 mg/dL and can be effectively addressed through carbohydrate intake.Severe hypoglycemia,denoted by blood glucose levels less than 54 mg/dL,poses a life-threatening risk if left untreated.Individuals with type 1 and type 2 diabetes undergoing insulin treatment are particularly susceptible to hypoglycemia due to impaired counterregulatory mechanisms.

关 键 词：IMPAIRED INTAKE CRITICAL 

分 类 号：R587.2[医药卫生—内分泌] R741[医药卫生—内科学]